Mass General Brigham/Dana-Farber Complex General Surgical Oncology Fellowship at Harvard Medical School

• To train surgical oncologists who will become national leaders in cancer treatment and research.
• To emphasize the importance of a multidisciplinary approach to cancer care.
• To familiarize fellows with the full armamentarium of treatments currently available to combat individual malignancies, as well as all relevant investigational therapies.
• To teach fellows how to conduct cancer research and design, lead new treatment protocols and facilitate the transfer of new discoveries from the laboratory into clinical practice.
• To teach the critical importance of the role of the patient and family support during all phases of the treatment process.
• To facilitate the understanding of the social and economic aspects of cancer treatment in an environment that emphasizes the highest levels of compassion and ethics.
• To ensure that graduating fellows are well-equipped to successfully pass the written and oral board examinations in complex surgical oncology.

• Rotations at Brigham and Women’s Hospital, Dana-Farber Cancer Institute and Massachusetts General Hospital.
• One fellow per year.
• August 1 start date.
• Eighteen months of clinical oncology training: Gastrointestinal, hepatobiliary, pancreas, breast, endocrine, cutaneous (melanoma) and soft tissue sarcoma malignancies
• Twelve months of surgical oncology.
• One month of medical oncology.
• One month of radiation oncology.
• One month of pathology.
• Two months of surgical electives.
• Six months of research training.
• Apprenticeship approach.
• Multidisciplinary training.
• Application deadline is mid-January.

Brigham and Women's Hospital is a scientific, clinical and academic powerhouse with a long history of firsts. We foster a shared commitment to predict, prevent and treat the world's toughest cancers. Our collaborations are changing the future of oncological care worldwide.

Our culture in providing excellence in multidisciplinary patient care, teaching and research affords an exceptional environment for clinical training and participation in exciting advances in basic and clinical research.

Committed to teaching and mentoring the next generation of surgeons and leaders in medicine, our faculty is comprised of experienced oncologists, who impart a breadth of knowledge and expertise during clinic and the operating room. In addition, basic and clinical research mentors provide many research opportunities for fellows.

Program Director

Mark Fairweather, MD
mfairweather@bwh.harvard.edu

Faculty at Dana-Farber Brigham Cancer Center

• Thomas E. Clancy, MD
• Laura S. Dominici, MD
• Jason L. Hornick, MD, PhD
• Olga Kantor, MD, MS
• Tari King, MD
• Harvey J. Mamon, MD, PhD
• Christina Minami, MD, MS
• Elizabeth Mittendorf, MD, PhD
• George Molina, MD, MPH
• Faina Nakhlis, MD
• Chandrajit P. Raut, MD, MSc
• Esther Rhei, MD
• Douglas Rubinson, MD, PhD
• Jiping Wang, MD, PhD
  

MGH Site Director

Genevieve Boland, MD, PhD
gmboland@mgh.harvard.edu

MGH Director of Professional Development

Sonia Cohen, MD, PhD
SCOHEN22@MGH.HARVARD.EDU

Faculty at MGH

• James Cusack, MD
• Keith Lillemoe, MD
• Carrie Cunningham, MD, MPH
• John Millen, MD
• Antonia Stephen, MD
• Kenneth Tanabe, MD
• Motaz Qadan, MD, PhD
• Richard Hodin, MD
• Rajshri Gartland, MD, MPH
• Roy Phitayakorn, MD

Brigham and Women’s Hospital is located in the Longwood Medical and Academic Area in Boston, Massachusetts. It is Harvard Medical School's second largest teaching affiliate. Along with Massachusetts General Hospital, it is one of the two founding members of Mass General Brigham, the largest health care provider in Massachusetts. Brigham and Women's Hospital is an international leader in virtually every area of medicine and has been the site of pioneering breakthroughs that have improved lives around the world.

Dana-Farber Cancer Institute (DFCI) provides care to children and adults with cancer, while advancing the understanding, diagnosis, treatment, cure, and prevention of cancer and related diseases. Dana-Farber cares for adults with cancer in specialized treatment centers focused on specific cancer types such as: lymphoma, leukemia, multiple myeloma, cutaneous (melanoma) cancer, breast cancer, gastrointestinal cancer, genitourinary cancer, gynecologic cancer, head and neck cancer, hematology, melanoma, neuro-oncology, sarcoma and thoracic (lung) cancer.

As an affiliate of Harvard Medical School and a National Cancer Institute-designated Comprehensive Cancer Center, DFCI also provides training for new generations of physicians and scientists, designs programs that promote public health, particularly among high-risk and underserved populations, and disseminates innovative patient therapies and scientific discoveries to target communities across the United States and throughout the world.

Massachusetts General Hospital (MGH) is located in the heart of Boston. MGH has five multidisciplinary care centers to offer patients comprehensive, state-of-the-art medical care. In addition, Mass General for Children provides a full range of pediatric health care services, from primary care, to treatments for complex and rare disorders.

For more information on our teaching facilities and other educational resources, please visit the Mass General Brigham Office of Graduate Medical Education.

• Applicants must have completed a residency in an ACGME-accredited general surgery program in the United States or Canada.
• Foreign students must have graduated from a medical school accredited by the Educational Commission for Foreign Medical Graduates

We require the following documents to be available for download through the Electronic Residency Application Service (ERAS) for an application to be reviewed:

• Curriculum vitae (CV)
• Medical school transcript
• Personal statement
• Three to five letters of recommendation
• USMLE transcript
• ABS in-training exam scores (on application)

For more information about applications and supporting documentation, please visit the Society of Surgical Oncology website.  

Each application is reviewed in its entirety with a focus toward a combination of overall academic excellence, leadership ability, career development potential and personal character.

We interview approximately 20 candidates for the fellowship. Although we receive applications from many well-qualified candidates, it is not possible to interview all who apply. Those who are invited will be notified approximately one month prior to the date of the scheduled interview.

We will conduct interviews virtually on May 7, 2025. All interviews are conducted in a single day.

Interviews are conducted virtually over Zoom.

The interview day begins with an introduction by the program director. Following the introduction, each candidate will meet with faculty from the Brigham and MGH. Current fellows will be on hand throughout the day to meet informally with the candidates between interviews.

Mark Fairweather, MD
Program Director
mfairweather@bwh.harvard.edu

Brigham and Women's Hospital
Division of Surgical Oncology
75 Francis Street
Boston, MA 02115